Avadel pharmaceuticals announces data supporting clinical profile for lumryz™ (sodium oxybate) for extended-release oral suspension (ciii) at world sleep 2023

– 17 abstracts accepted, including new and encore data emphasizing clinical benefit and patient preference for a once-at-bedtime narcolepsy treatment option –

AVDL Ratings Summary

AVDL Quant Ranking